Patent · US Expired

Quantitative determination of antithrombin III

US4106990A · kind A · utility

6Cited by

3References

3Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Hermann E. Karges · Marburg, DE
Norbert Heimburger

Key dates

Filing date	Jun 10, 1976
Grant date	Aug 15, 1978
Priority date	—
Expiry date	Jun 10, 1996

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/108331
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Antithrombin III in plasma or serum is determined by combining diluted plasma or serum with heparin or heparinoids and thrombin to form a mixture, permitting the mixture to stand, thereafter adding to the mixture a fibrinogen solution and determining the coagulation time. The heparin or heparinoids and thrombin can be combined together to form a reagent for use in the determination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.